Oxidative Stress and Inflammation Biomarker Expression in Obstructive Sleep Apnea Patients.
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic methodology or primary human data
PubMed 33451164 · doi:10.3390/jcm10020277
What was done
This was a narrative literature review evaluating oxidative stress and inflammatory biomarkers tested in patients with Obstructive Sleep Apnea Syndrome (OSAS). The authors reviewed published evidence discussing the mechanism of intermittent hypoxia and hypercapnia leading to reactive oxygen species production and cytokine expression, as well as biomarker correlations with disease severity and treatment.
What was found
The abstract reports no numerical data, pooled effect sizes, or study counts. It qualitatively reports that OSAS-related intermittent hypoxia drives oxidative imbalance, reactive oxygen species generation, lipid peroxidation, cell-free DNA elevation, and increases in tumor necrosis factors and interleukins (IL-2, IL-4, IL-6). The authors report that the literature has not yet established which specific inflammatory biomarkers best correlate with OSAS diagnosis, clinical progression, or comorbidities.
Why it matters
Clarifying the molecular cascade from intermittent hypoxia to systemic inflammation helps explain how sleep apnea contributes to broader systemic disease, though clinically actionable diagnostic biomarkers remain undefined.
Limits
The abstract describes a narrative review without systematic search protocols, meta-analytic pooling, or new empirical data. No specific sample sizes, effect estimates, or diagnostic accuracy metrics (such as sensitivity or specificity) are reported.
Cited by
- supports Intermittent hypoxia from conditions such as sleep apnea generates reactive oxygen species (ROS).